PASADENA, Calif. Click here to read the full issue brief, "Drug Pricing Proposals Threaten America's Most Vulnerable Patients." "It's a relief that Americans oppose Congress's drug pricing proposals once voters learn the true consequences of these misguided reforms," said Sally C. Pipes, the brief's co-author and PRI president, CEO, and Thomas W. Smith Fellow in Health Care Policy.
LONDON, Oct. 18, 2021 According to Brandessence market research, the dietary supplement market reached a valuation of USD 138.9 billion in 2020. "Due to growing health concerns caused by covid-19, the demand for dietary supplements remains at an all-time high.
NEW YORK, Oct. 15, 2021 The interstitial cystitis drugs market is expected to grow by USD 283.95 mn from 2021 to 2025, progressing at a CAGR of 5.06%, according to Technavio. Request a Free Sample Report to explore more growth opportunities in the interstitial cystitis drugs market.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
Log In Required
